FY2025 · ended Dec 31, 2025 · Revenue $1.37B, +5.2% YoY · Filed Feb 17, 2026
Conmed Corporation (CNMD) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.4 billion and net income of $47.1 million. Free cash flow was $150.9 million. As of Sep 30, 2026 it held $48.0 million in cash and investments and $635.8 million in total debt.
Revenue (TTM)
$1.37B
+1.6% vs year-ago TTM
Net income (TTM)
$73.43M
+14.6% vs year-ago TTM
Operating cash flow (TTM)
$146.31M
-12.7% vs year-ago TTM
Free cash flow (TTM)
$132.69M
-10.9% vs year-ago TTM
EPS (TTM)
$2.41
+17.1% vs year-ago TTM
Dividend per share
$0.60
-25.0% vs prior year
Shares outstanding
30.83M
-0.2% vs prior year
Net cash
$-587.78M
as of Sep 30, 2026
Operating margin
9.9%
FY 2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- CNMD (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Largo, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 816956
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.2B | $1.0B | $1.0B |
| Operating income | $102.6M | $200.3M | $120.6M | $70.1M | $109.7M |
| Net income | $47.1M | $132.4M | $64.5M | -$80.6M | $62.5M |
| Diluted EPS | $1.51 | $4.25 | $2.04 | -$2.68 | $1.94 |
| Operating cash flow | $170.7M | $167.0M | $125.3M | $33.4M | $111.8M |
| Free cash flow | $150.9M | $153.9M | $106.3M | $11.6M | $96.9M |
| Total assets | $2.3B | $2.3B | $2.3B | $2.3B | $1.8B |
| Total liabilities | $1.3B | $1.3B | $1.5B | $1.6B | $980.6M |
| Stockholders' equity | $1.0B | $962.7M | $834.2M | $745.5M | $785.4M |
| Cash and investments | $40.8M | $24.5M | $24.3M | $28.9M | $20.8M |
| Total debt | $886.8M | $946.4M | $990.5M | $1.0B | $692.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 4, 2026 | Jun 3, 2026 |
All 1000 Conmed Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.